BioVoice News October 2017 Issue 5 Volume 2 | Page 38

expert corner large scale and we are convinced that only technology can help to address this problem at a mass scale. What we need is a large scale, clinically validated, clinician led program to be deployed for diabetes management. We are also convinced that an equal participation from care givers (diabetic educators, patient’s family and friends) would be 38 BioVoiceNews | October 2017 required to tackle the menace. We are also convinced that a large scale insurance play is waiting to unveil to manage chronic disease in a mass scale. We are developing our product keeping these challenges and keeping the solutions in mind. We are using the power of Artificial Intelligence and data to invent the field of digital diabetology. Through our technology we are empowering clinicians to deploy an individualized care plan, through our patient app we are empowering the patient to monitor his condition and take corrective actions through real time logging, reminders and feedback, through our coach platform we are empowering both clinician and patients